GI cancers to double by 2050, experts warn

Gastrointestinal cancer cases are expected to double worldwide by 2050, according to a multi-institutional study co-led by Cedars-Sinai. The projections, based on 2022 data and published in the journal Cancer, conclude that ...

Molecular target drives immunogenicity in cancer immunotherapy

Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as a potential "switch" that can modulate a type of cancer cell death known as immunogenic cell death ...

Research reveals medication information risks in aged care

A new report from Griffith University has found that fragmented medication systems in Australian aged care are driving high rates of medication discrepancies and avoidable hospital admissions—costing the health system an ...

page 1 from 40